Clinical evaluation of sandostene, a new antihistaminic drug, in allergic diseases; results of a double-blind investigation.
D018926:Anti-Allergic Agents; D004311:Double-Blind Method; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006967:Hypersensitivity / Q000628:therapy*; D007154:Immune System Diseases
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists
ALLERGY/therapy; ANTIHISTAMINICS/therapeutic use